A) "Gastrointestinal symptoms are common with this medication."
B) "People taking this drug should not take antihistamines."
C) "This drug helps neurons that aren't already damaged to function better."
D) "This drug significantly slows the progression of the disease."
Correct Answer
verified
Multiple Choice
A) Notify the provider of this patient's worsening symptoms.
B) Prepare the patient's spouse for impending death from Alzheimer's disease.
C) Request an increase in the medication dose to treat the exacerbation in symptoms.
D) Tell the spouse that this is an expected progression of the disease.
Correct Answer
verified
Multiple Choice
A) "Doses are lower but more steady with the transdermal patch."
B) "Reduced side effects occur with the transdermal patch."
C) "We only need to change the patch every 2 weeks."
D) "We should remove the old patch before applying the new one."
Correct Answer
verified
Multiple Choice
A) "A diagnosis is made by administering medications and observing for potential improvement in symptoms."
B) "The diagnosis is based on a patient's age, family history, serum apolipoproteins, and genetic testing."
C) "Magnetic resonance imaging to demonstrate brain atrophy is the definitive test to determine Alzheimer's disease."
D) "Proposed diagnostic criteria include measures of cognitive function and the presence of one known biomarker."
Correct Answer
verified
Multiple Choice
A) "Memantine is indicated for patients with mild to moderate Alzheimer's disease."
B) "Memantine modulates the effects of glutamate to alter calcium influx into neurons."
C) "Memantine prevents calcium from leaving neurons, which improves their function."
D) "When used with donepezil, memantine increases the amount of calcium in neuronal cells."
Correct Answer
verified
Multiple Choice
A) Confusion and memory impairment
B) Dizziness and headache
C) Nausea, vomiting, and diarrhea
D) Slowed heart rate and lightheadedness
Correct Answer
verified
Multiple Choice
A) Advanced age
B) Alcoholism
C) Family history
D) Gender
E) Obesity
Correct Answer
verified
Multiple Choice
A) Family history and female gender are both known to increase the risk.
B) Genetic testing can provide a definitive measure of the risk.
C) Patients with the apolipoprotein E2 gene (ApoE2) are more likely to develop the disease.
D) Some biologic markers can be measured, but none is known to increase the risk.
Correct Answer
verified
Multiple Choice
A) The dose can be increased, because the patient has been taking the drug for longer than 3 months.
B) The dose can be increased to twice daily dosing instead of once daily dosing.
C) The increase in symptoms is the result of hepatotoxicity from the medication's side effects.
D) The patient must take the drug for longer than 1 year before the dose can be increased.
Correct Answer
verified
Showing 1 - 9 of 9
Related Exams